Granahan Investment Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,081
| Closed | -$307K | – | 214 |
|
|
2020
Q4 | $307K | Sell |
5,081
-551
| -10% | -$33.3K | 0.01% | 191 |
|
|
2020
Q3 | $750K | Buy |
5,632
+99
| +2% | +$13.2K | 0.03% | 170 |
|
|
2020
Q2 | $933K | Buy |
5,533
+4,497
| +434% | +$758K | 0.03% | 168 |
|
|
2020
Q1 | $149K | Sell |
1,036
-30
| -3% | -$4.32K | 0.01% | 184 |
|
|
2019
Q4 | $352K | Buy |
1,066
+122
| +13% | +$40.3K | 0.02% | 171 |
|
|
2019
Q3 | $472K | Buy |
944
+17
| +2% | +$8.5K | 0.03% | 170 |
|
|
2019
Q2 | $563K | Buy |
927
+2
| +0.2% | +$1.22K | 0.03% | 176 |
|
|
2019
Q1 | $565K | Sell |
925
-45
| -5% | -$27.5K | 0.03% | 183 |
|
|
2018
Q4 | $354K | Sell |
970
-19
| -2% | -$6.93K | 0.03% | 181 |
|
|
2018
Q3 | $668K | Buy |
+989
| New | +$668K | 0.04% | 184 |
|